A Phase 2 Double-Blind, Placebo-Controlled Multi-dose Study to Investigate Etokimab (ANB020) Activity in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2019
At a glance
- Drugs Etokimab (Primary)
- Indications Nasal polyps; Rhinosinusitis
- Focus Therapeutic Use
- Acronyms ECLIPSE
- Sponsors AnaptysBio
- 30 Jan 2019 Status changed from not yet recruiting to recruiting.
- 13 Aug 2018 New trial record
- 07 Aug 2018 According to an AnaptysBio media release, the Company plans to initiate this study by the end of 2018 and anticipates top-line data in the second half of 2019.